Onderneming PHAXIAM Therapeutics S.A. Euronext Paris
Aandelen
PHXM
FR0011471135
Biotechnologie & Medisch Onderzoek
Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,98 EUR | -0,50% | +2,23% | -35,22% |
21/03 | Transcript : PHAXIAM Therapeutics S.A., Q4 2023 Earnings Call, Mar 21, 2024 | |
20/03 | PHAXIAM Therapeutics S.A. rapporteert resultaten voor het volledige jaar afgesloten op 31 december 2023 | CI |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23-06-23 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23-06-23 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-23 |
Cindy Fevre
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-23 |
Céline Breda
CTO | Chief Tech/Sci/R&D Officer | 54 | 23-06-23 |
Karine Charton
PRN | Corporate Officer/Principal | - | 23-06-23 |
General Counsel | - | 23-06-23 | |
Human Resources Officer | - | 23-06-23 | |
Jérôme Bailly
PRN | Corporate Officer/Principal | 45 | 23-06-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 23-06-23 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23-06-23 |
Gil Beyen
BRD | Director/Board Member | 62 | 23-06-23 |
Martine George
BRD | Director/Board Member | 76 | 23-06-23 |
Director/Board Member | 66 | 23-06-23 | |
Didier Hoch
CHM | Chairman | 68 | 23-06-23 |
Leila Nicolas
BRD | Director/Board Member | - | 23-06-23 |
Robert Sebbag
BRD | Director/Board Member | 73 | 23-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 101 855 | 2 857 819 ( 92,13 %) | 250 ( 0,008060 %) | 92,13 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
250 | 0.00% | 821 $ |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-36,53% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |
- Beurs
- Aandelen
- Aandeel PHAXIAM Therapeutics S.A.
- Aandeel PHAXIAM Therapeutics S.A. - Euronext Paris
- Onderneming PHAXIAM Therapeutics S.A.